Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ioannis Baltas

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Clinical Medicine (London, England)|November 8, 2024
Staphylococcus aureus bacteraemia for the general physician: A narrative review of a metastatic infection with malignant complicationsRonak J Shah, Ioannis Baltas
Jac-Antimicrobial Resistance|February 19, 2026
Exploring the perspectives of antimicrobial stewardship pharmacists in England on the subscription model for antimicrobial drugsStephen Hughes, Ioannis Baltas, Mark Gilchrist
The Journal of Antimicrobial Chemotherapy|November 6, 2024
Resistance profiles of carbapenemase-producing Enterobacterales in a large centre in England: are we already losing cefiderocol?Ioannis Baltas, Trupti Patel, Ana Lima Soares
The Journal of Antimicrobial Chemotherapy|March 11, 2025
Resistance profiles of carbapenemase-producing Enterobacterales in a large centre in England: are we already losing cefiderocol?-authors' responseIoannis Baltas, Trupti Patel, Ana Lima Soares
The Journal of Antimicrobial Chemotherapy|March 4, 2025
Resistance profiles of carbapenemase-producing Enterobacterales in a large centre in England: are we already losing cefiderocol?-right to reply-authors' responseIoannis Baltas, Trupti Patel, Ana Lima Soares
Jac-Antimicrobial Resistance|December 20, 2024
Antimicrobial resistance-attributable mortality: a patient-level analysisIoannis Baltas, Timothy Miles Rawson, Hamish Houston, et al.
The Journal of Antimicrobial Chemotherapy|October 21, 2025
The Achilles' heel of the Trojan Horse? A systematic evaluation of cefiderocol susceptibility testingDeny Tsakri, Stefanos Ferous, Ioannis Baltas, et al.
Jac-Antimicrobial Resistance|April 18, 2024
Antimicrobial stewardship markers and healthcare-associated pneumonia threshold criteria in UK hospitals: analysis of the MicroGuide<sup>Tm</sup> applicationLuke S P Moore, Ioannis Baltas, James Amos, et al.
Journal of Medical Microbiology|June 26, 2024
Ciprofloxacin prophylaxis during haematopoietic cell transplantation: a role for use in patients with germ cell tumours?Konstantinos Kavallieros, Ioannis Baltas, Giannis Konstantinou, et al.
Jac-Antimicrobial Resistance|February 2, 2024
The effect of ciprofloxacin prophylaxis during haematopoietic cell transplantation on infection episodes, exposure to treatment antimicrobials and antimicrobial resistance: a single-centre retrospective cohort studyIoannis Baltas, Konstantinos Kavallieros, Giannis Konstantinou, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Clinical Medicine (London, England)|November 8, 2024
Staphylococcus aureus bacteraemia for the general physician: A narrative review of a metastatic infection with malignant complicationsRonak J Shah, Ioannis Baltas
Jac-Antimicrobial Resistance|February 19, 2026
Exploring the perspectives of antimicrobial stewardship pharmacists in England on the subscription model for antimicrobial drugsStephen Hughes, Ioannis Baltas, Mark Gilchrist
The Journal of Antimicrobial Chemotherapy|November 6, 2024
Resistance profiles of carbapenemase-producing Enterobacterales in a large centre in England: are we already losing cefiderocol?Ioannis Baltas, Trupti Patel, Ana Lima Soares
The Journal of Antimicrobial Chemotherapy|March 11, 2025
Resistance profiles of carbapenemase-producing Enterobacterales in a large centre in England: are we already losing cefiderocol?-authors' responseIoannis Baltas, Trupti Patel, Ana Lima Soares
The Journal of Antimicrobial Chemotherapy|March 4, 2025
Resistance profiles of carbapenemase-producing Enterobacterales in a large centre in England: are we already losing cefiderocol?-right to reply-authors' responseIoannis Baltas, Trupti Patel, Ana Lima Soares
Jac-Antimicrobial Resistance|December 20, 2024
Antimicrobial resistance-attributable mortality: a patient-level analysisIoannis Baltas, Timothy Miles Rawson, Hamish Houston, et al.
The Journal of Antimicrobial Chemotherapy|October 21, 2025
The Achilles' heel of the Trojan Horse? A systematic evaluation of cefiderocol susceptibility testingDeny Tsakri, Stefanos Ferous, Ioannis Baltas, et al.
Jac-Antimicrobial Resistance|April 18, 2024
Antimicrobial stewardship markers and healthcare-associated pneumonia threshold criteria in UK hospitals: analysis of the MicroGuide<sup>Tm</sup> applicationLuke S P Moore, Ioannis Baltas, James Amos, et al.
Journal of Medical Microbiology|June 26, 2024
Ciprofloxacin prophylaxis during haematopoietic cell transplantation: a role for use in patients with germ cell tumours?Konstantinos Kavallieros, Ioannis Baltas, Giannis Konstantinou, et al.
Jac-Antimicrobial Resistance|February 2, 2024
The effect of ciprofloxacin prophylaxis during haematopoietic cell transplantation on infection episodes, exposure to treatment antimicrobials and antimicrobial resistance: a single-centre retrospective cohort studyIoannis Baltas, Konstantinos Kavallieros, Giannis Konstantinou, et al.
Pageof 3